Zenith Drugs bulk deals and insider trading
NSE: ZENITHDRUGPharmaceuticals & Biotechnology
Share price at the NSE close on 23 Oct 2026. Previous close ₹38.20.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹68 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 15 Jun 2026
- 17.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 15 Jun 2026
- 0.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 15 Jun 2026
- 5.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 15 Jun 2026
- 0.75
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 3,20075.0% delivered
Promoter and insider buying and selling
Trades made since 23 Oct 2025.Zenith Drugs promoter holding
No promoter, director, key manager or employee bought or sold on the market.
- Promoters and promoter group: no market trade
Zenith Drugs insider trading
All 6 disclosures on record.Insider trading, all companies
Jun 2026
- SANDEEP BHARDWAJ₹16 Cr36,66,990 sharesBought · Promoter And Designated Person · 23 Jun 2026 · disclosed 29 Jun
- AJAY SINGH DASSUNDI₹16 Cr38,61,990 sharesSold or invoked · Promoter And Designated Person · 23 Jun 2026 · disclosed 29 Jun
- SANDEEP BHARDWAJ₹16 Cr36,66,990 sharesSold or invoked · Promoter And Designated Person · 23 Jun 2026 · disclosed 29 Jun
- BHUPESH SONI₹15 Cr34,60,980 sharesBought · Promoter And Designated Person · 23 Jun 2026 · disclosed 29 Jun
- AJAY SINGH DASSUNDI₹16 Cr38,61,990 sharesBought · Promoter And Designated Person · 23 Jun 2026 · disclosed 29 Jun
- BHUPESH SONI₹15 Cr34,60,980 sharesSold or invoked · Promoter And Designated Person · 23 Jun 2026 · disclosed 29 Jun
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Zenith Drugs bulk deals
Last 12 months, since 23 Oct 2025: 3 bulk deals, ₹1.18 Cr bought and ₹1.18 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Wednesday 16 Sep 20262 firms · ₹0.79 Cr bought · ₹0.79 Cr soldNet nil
- SoldAMIT GARGSold 1,84,000 at ₹43.101.07% of the company₹0.79 Cr
- BoughtBINDU GARGBought 1,84,000 at ₹43.101.07% of the company₹0.79 Cr
Monday 10 Aug 20262 firms · ₹0.39 Cr bought · ₹0.38 Cr soldNet bought ₹72,264
- BoughtAMIT GARGBought 95,200 at ₹41.070.56% of the company₹0.39 Cr
- SoldBINDU GARGSold 93,600 at ₹41.000.55% of the company₹0.38 Cr
Monday 7 Jul 20251 firm · ₹0 bought · ₹0.77 Cr soldNet sold ₹0.77 Cr
- SoldKAVYA GUPTASold 1,04,000 at ₹74.000.61% of the company₹0.77 Cr
Tuesday 1 Oct 20241 firm · ₹0 bought · ₹1.14 Cr soldNet sold ₹1.14 Cr
- SoldPRIYANKA .Sold 86,400 at ₹131.810.50% of the company₹1.14 Cr
Thursday 29 Aug 20241 firm · ₹0.02 Cr bought · ₹1.00 Cr soldNet sold ₹0.98 Cr
- Both waysGRETEX SHARE BROKING LIMITEDBought 1,600 at ₹115.30Sold 88,000 at ₹113.640.51% of the companyNet −86,400 shares₹0.02 Cr bought
Thursday 22 Aug 20241 firm · ₹0.80 Cr bought · ₹0 soldNet bought ₹0.80 Cr
- BoughtRASHMI RANI PAHWABought 88,000 at ₹90.350.51% of the company₹0.80 Cr
Friday 12 Jul 20242 firms · ₹0.61 Cr bought · ₹0.61 Cr soldNet nil
- BoughtKINGSMAN WEALTH FUND PCC - KIF IIBought 96,000 at ₹63.150.56% of the company₹0.61 Cr
- SoldNEOMILE GROWTH FUND - SERIES ISold 96,000 at ₹63.150.56% of the company₹0.61 Cr
Monday 1 Apr 20241 firm · ₹1.63 Cr bought · ₹2.64 Cr soldNet sold ₹1.01 Cr
- Both waysYUGA STOCKS AND COMMODITIES PRIVATE LIMITED .Bought 2,22,400 at ₹73.33Sold 3,77,600 at ₹69.962.20% of the companyNet −1,55,200 shares₹1.63 Cr bought
Wednesday 13 Mar 20241 firm · ₹0 bought · ₹0.64 Cr soldNet sold ₹0.64 Cr
- SoldYUGA STOCKS AND COMMODITIES PRIVATE LIMITED .Sold 1,00,800 at ₹63.730.59% of the company₹0.64 Cr
Thursday 29 Feb 20242 firms · ₹2.85 Cr bought · ₹1.44 Cr soldNet bought ₹1.41 Cr
- BoughtYUGA STOCKS AND COMMODITIES PRIVATE LIMITED .Bought 3,00,800 at ₹94.91₹2.85 Cr
- SoldMULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDSold 1,52,000 at ₹94.90₹1.44 Cr
Wednesday 28 Feb 20241 firm · ₹0 bought · ₹1.52 Cr soldNet sold ₹1.52 Cr
- SoldMULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDSold 1,52,000 at ₹99.90₹1.52 Cr
Tuesday 27 Feb 20241 firm · ₹3.22 Cr bought · ₹0 soldNet bought ₹3.22 Cr
- BoughtMULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDBought 3,04,000 at ₹106.01₹3.22 Cr
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 16 deals on record since listing on 27 Feb 2024.